Special Survey for Type 1 or Type 2 Diabetic Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01487408

Enrollment

1463

Registered

2011-12-07

Start date

2002-04-30

Completion date

2009-10-31

Last updated

2016-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia episodes under normal clinical practice for patients with type 1 or type 2 diabetes.

Interventions

DRUGinsulin aspart

Adminstered subcutaneously (s.c., under the skin). Prescribed by physician as a results of normal clinical practice

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with diabetes requiring insulin therapy

Exclusion criteria

* Patients who had not been treated more than 3 months at the same investigational site * Patients who had treatment history of NovoRapid® (insulin aspart)

Design outcomes

Primary

Measure	Time frame
HbA1c (glycosylated haemoglobin)	—

Secondary

Measure	Time frame
Incidence of servere hypoglycaemia	—
Total dose of insulin (aspart/human insulin) infused subcutaneously	—
Physical examination	—
Adverse events	—

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026